Immunotherapy Product Animation
Scientific Animation | Consistent Brand Identity & Scientific Education
We created this medical animation for Spectrum Pharmaceuticals for their immunotherapy product, Poziotinib®. The animation begins with the mechanism of disease of EGFR-positive and HER2-positive cancers, exploring how mutations in these genes result in uncontrolled cancer cell growth.
Poziotinib® is an investigational, orally-administered, irreversible tyrosine kinase inhibitor targeting EGFR and HER2 with exon 20 insertion mutations. Pre-clinical studies indicate that Poziotinib® inhibits kinase activity of EGFR and HER2 with exon 20 insertion mutations, inhibiting proliferation, and promoting cancer cell death. Poziotinib® is in development for the treatment of Non-Small Cell Lung Cancer (NSCLC) and breast cancer.